Tokyo Tape
Sign in
← Fukuda Denshi

Quarterly report · Q3

6960.TEDINET S100ST0Z
Period2023-04-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥99.3bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥134.6bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥93.5bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥19.3bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥16.1bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥19.6bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥25.1bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥16.8bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥19.8bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥16.9bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥13.6bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥17.3bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥11.6bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥13.6bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥11.6bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥210.7bnat 2023-12-31Cons.Assets
Total assets¥206.9bnat 2023-03-31Cons.Assets
Total assets¥195.2bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥37.5bnat 2023-12-31Cons.Liabilities
Total liabilities¥43.9bnat 2023-03-31Cons.Liabilities
Net assets / equity¥173.2bnat 2023-12-31Cons.Net assets
Net assets / equity¥163.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥156.6bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥65.9bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥68.0bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥450.772023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥126.462023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥571.252022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥383.712022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥115.282022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio82.2%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio78.8%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio80.2%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue2023-04-01 → 2023-12-31¥29.7bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue external2023-04-01 → 2023-12-31¥29.7bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentsegment profit2023-04-01 → 2023-12-31¥5.4bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2023-04-01 → 2023-12-31¥44.1bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2023-04-01 → 2023-12-31¥44.1bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2023-04-01 → 2023-12-31¥9.4bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2023-04-01 → 2023-12-31¥6.0bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2023-04-01 → 2023-12-31¥6.0bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2023-04-01 → 2023-12-31¥1.1bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2023-04-01 → 2023-12-31¥19.5bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2023-04-01 → 2023-12-31¥19.5bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2023-04-01 → 2023-12-31¥3.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥99.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥99.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥19.3bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥25.5bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥25.5bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥2.9bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2022-04-01 → 2022-12-31¥40.5bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2022-04-01 → 2022-12-31¥40.5bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2022-04-01 → 2022-12-31¥8.9bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2022-04-01 → 2022-12-31¥7.5bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2022-04-01 → 2022-12-31¥7.5bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.2bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2022-04-01 → 2022-12-31¥20.0bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2022-04-01 → 2022-12-31¥20.0bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2022-04-01 → 2022-12-31¥3.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥93.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥93.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥16.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 365
ItemContextValueUnit
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member8674300
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.2214
Number of shares held in own name treasury shares etcCurrentQuarterInstant8674300
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant8674300
Shareholding ratio treasury shares etcCurrentQuarterInstant0.2214
Cash and depositsPrior1YearInstant67965000000JPY
Cash and depositsCurrentQuarterInstant65884000000JPY
Notes and accounts receivable tradePrior1YearInstant37944000000JPY
Notes and accounts receivable tradeCurrentQuarterInstant31354000000JPY
Electronically recorded monetary claims operating caPrior1YearInstant3156000000JPY
Electronically recorded monetary claims operating caCurrentQuarterInstant4324000000JPY
Short term investment securitiesPrior1YearInstant501000000JPY
Short term investment securitiesCurrentQuarterInstant－JPY
Merchandise and finished goodsPrior1YearInstant10109000000JPY
Merchandise and finished goodsCurrentQuarterInstant14737000000JPY
Work in processPrior1YearInstant212000000JPY
Work in processCurrentQuarterInstant348000000JPY
Raw materials and suppliesPrior1YearInstant5277000000JPY
Raw materials and suppliesCurrentQuarterInstant5540000000JPY
Other caPrior1YearInstant1562000000JPY
Other caCurrentQuarterInstant1614000000JPY
Allowance for doubtful accounts caPrior1YearInstant-5000000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-6000000JPY
Current assetsPrior1YearInstant126725000000JPY
Current assetsCurrentQuarterInstant123798000000JPY
Property plant and equipmentPrior1YearInstant46826000000JPY
Property plant and equipmentCurrentQuarterInstant51940000000JPY
Intangible assetsPrior1YearInstant1617000000JPY
Intangible assetsCurrentQuarterInstant1578000000JPY
Investment securitiesPrior1YearInstant10815000000JPY
Investment securitiesCurrentQuarterInstant13038000000JPY
Other ioaPrior1YearInstant20951000000JPY
Other ioaCurrentQuarterInstant20389000000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-14000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-8000000JPY
Investments and other assetsPrior1YearInstant31753000000JPY
Investments and other assetsCurrentQuarterInstant33418000000JPY
Noncurrent assetsPrior1YearInstant80197000000JPY
Noncurrent assetsCurrentQuarterInstant86938000000JPY
AssetsPrior1YearInstant206922000000JPY
AssetsCurrentQuarterInstant210737000000JPY
Notes and accounts payable tradePrior1YearInstant13743000000JPY
Notes and accounts payable tradeCurrentQuarterInstant14572000000JPY
Electronically recorded obligations operating clPrior1YearInstant5136000000JPY
Electronically recorded obligations operating clCurrentQuarterInstant5293000000JPY
Short term loans payablePrior1YearInstant1750000000JPY
Short term loans payableCurrentQuarterInstant1800000000JPY
Income taxes payablePrior1YearInstant4103000000JPY
Income taxes payableCurrentQuarterInstant669000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass